Genetic and shared environmental risk factors do not lead to eosinophil activation in healthy twins of IBD patients

References

• Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc. 2019;94(1):155–165.
   PubMed Web of Science ®Google Scholar
• Salim SY, Söderholm JD. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17(1):362–381.
   PubMed Web of Science ®Google Scholar
• Filippone RT, Sahakian L, Apostolopoulos V, et al. Eosinophils in inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(7):1140–1151.
   PubMed Web of Science ®Google Scholar
• Davoine F, Lacy P. Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol. 2014;5:570.
   PubMed Web of Science ®Google Scholar
• Venge P. The eosinophil and airway remodelling in asthma. Clin Respir J. 2010;4(Suppl 1):15–19.
   PubMedGoogle Scholar
• Blanchard C, Rothenberg ME. Chapter 3: biology of the eosinophil. Adv Immunol. 2009;101:81–121.
   PubMed Web of Science ®Google Scholar
• Lampinen M, Rönnblom A, Amin K, et al. Eosinophil granulocytes are activated during the remission phase of ulcerative colitis. Gut. 2005;54(12):1714–1720.
   PubMed Web of Science ®Google Scholar
• Lampinen M, Backman M, Winqvist O, et al. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis. J Leukoc Biol. 2008;84(6):1392–1399.
   PubMed Web of Science ®Google Scholar
• Torres J, Burisch J, Riddle M, et al. Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities. Gut. 2016;65(7):1061–1069.
   PubMed Web of Science ®Google Scholar
• Keita ÅV, Lindqvist CM, Öst Å, et al. Gut barrier dysfunction: a primary defect in twins with Crohn’s disease predominantly caused by genetic predisposition. J Crohns Colitis. 2018;12(10):1200–1209.
   PubMed Web of Science ®Google Scholar
• Zhuhlina Y, Hahn-Strömberg V, Shamikh A, et al. Subclinical inflammation with increased neutrophil activity in healthy twin siblings reflect environmental influence in the pathogenesis of inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(8):1725–1731.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659–667.
   PubMed Web of Science ®Google Scholar
• Magnusson PK, Almqvist C, Rahman I, et al. The Swedish Twin Registry: establishment of a biobank and other recent developments. Twin Res Hum Genet. 2013;16(1):317–329.
   PubMed Web of Science ®Google Scholar
• Silverberg MS1, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl a):5A–36A.
   PubMed Web of Science ®Google Scholar
• Lichtenstein P, De Faire U, Floderus B, et al. The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies. J Intern Med. 2002;252(3):184–205.
   PubMed Web of Science ®Google Scholar
• Peterson CG, Eklund E, Taha Y, et al. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease. Am J Gastroenterology. 2002;97(7):1755–1762.
   PubMed Web of Science ®Google Scholar
• Geboes K, Riddell R, Ost A, et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut. 2000;47(3):404–409.
   PubMed Web of Science ®Google Scholar
• Carlin JB, Gurrin LC, Sterne JA, et al. Regression models for twin studies: a critical review. Int J Epidemiol. 2005;34(5):1089–1099.
   PubMed Web of Science ®Google Scholar
• Bland JM, Altman DG. Statistics Notes: the use of transformation when comparing two means. BMJ. 1996;312(7039):1153.
   PubMed Web of Science ®Google Scholar
• Piegorsch WW. Design and analysis of reliability studies: the statistical evaluation of measurement errors. Graham Dunn, Oxford University Press, New York, 1989. Statist Med. 1991;10(1):156–158.
   Google Scholar
• Bouchard TJ, McGue M. Genetic and environmental influences on human psychological differences. J Neurobiol. 2003;54(1):4–45.
   PubMedGoogle Scholar
• Bischoff SC, Wedemeyer J, Herrmann A, et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology. 1996;28(1):1–13.
   PubMed Web of Science ®Google Scholar
• Rothenberg ME, Mishra A, Brandt EB, et al. Gastrointestinal eosinophils. Immunol Rev. 2001;179(1):139–155.
   PubMedGoogle Scholar
• Carlson M, Raab Y, Peterson C, et al. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. Am J Gastroenterol. 1999;94(7):1876–1883.
   PubMed Web of Science ®Google Scholar
• Lefrançais E, Roga S, Gautier V, et al. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci Usa. 2012;109(5):1673–1678.
   PubMed Web of Science ®Google Scholar
• Angulo EL, McKernan EM, Fichtinger PS, et al. Comparison of IL-33 and IL-5 family mediated activation of human eosinophils. PLoS One. 2019;14(9):e0217807.
   PubMed Web of Science ®Google Scholar
• Bergemalm D, Andersson E, Karlin P, et al. Markers of systemic inflammation in preclinical ulcerative colitis. Abstract United European Gastroenterol J. 2019;7(8 suppl):111.
   Google Scholar
• DeBrosse CW, Case JW, Putnam PE, et al. Quantity and distribution of eosinophils in the gastrointestinal tract of children. Pediatr Dev Pathol. 2006;9(3):210–218.
   PubMed Web of Science ®Google Scholar
• Matsushita T, Maruyama R, Ishikawa N, et al. The number and distribution of eosinophils in the adult human gastrointestinal tract: a study and comparison of racial and environmental factors. Am J Surg Pathol. 2015;39(4):521–527.
   PubMed Web of Science ®Google Scholar
• Amcoff K, Joossens M, Pierik MJ, et al. Concordance in Anti-OmpC and Anti-I2 indicate the influence of genetic predisposition: results of a European Study of Twins with Crohn's Disease. J Crohns Colitis. 2016;10(6):695–702.
   PubMed Web of Science ®Google Scholar
• Halfvarson J, Standaert-Vitse A, Järnerot G, et al. Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease. Gut. 2005;54(9):1237–1243.
   PubMed Web of Science ®Google Scholar
• Dicksved J, Halfvarson J, Rosenquist M, et al. Molecular analysis of the gut microbiota of identical twins with Crohn’s disease. Isme J. 2008;2(7):716–727.
   PubMed Web of Science ®Google Scholar
• Willing B, Halfvarson J, Dicksved J, et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn’s disease. Inflamm Bowel Dis. 2009;15(5):653–660.
   PubMed Web of Science ®Google Scholar
• Willing BP, Dicksved J, Halfvarson J, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010;139(6):1844–1854.
   PubMed Web of Science ®Google Scholar